Advertisement

Polypharmacy in Older Adults

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Geriatric Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Colby S.L.
        • Ortman J.M.
        Projections of the size and composition of the U.S. population: 2014 to 2060, current population reports, P25-1143.
        U.S. Census Bureau, Washington (DC)2014
        • Shah B.M.
        • Hajjar E.R.
        Polypharmacy, adverse drug reactions, and geriatric syndromes.
        Clin Geriatr Med. 2012; 28: 173-186
        • Ward B.W.
        • Schiller J.S.
        • Goodman R.A.
        Multiple chronic conditions among US adults: a 2012 update.
        Prev Chronic Dis. 2014; 11: 130389
        • Khezrian M.
        • McNeil C.J.
        • Murray A.D.
        • et al.
        An overview of prevalence, determinants and health outcomes of polypharmacy.
        Ther Adv Drug Saf. 2020; 11
        • Masnoon N.
        • Shakib S.
        • Kalisch-Ellett L.
        • et al.
        What is polypharmacy? A systematic review of definitions.
        BMC Geriatr. 2017; 17: 230
        • Bjerrum L.
        • Rosholm J.
        • Hallas J.
        • et al.
        Methods of estimating the occurrence of polypharmacy by means of prescription database.
        E J Clin Pharmacol. 1997; 53: 7-11
        • Davies L.E.
        • Spiers G.
        • Kingston A.
        • et al.
        Adverse outcomes of polypharmacy in older people: systematic review of reviews.
        J Am Med Dir Assoc. 2020; 21: 181-187
        • Turnheim K.
        Drug dosage in the elderly. Is it rational?.
        Drug Aging. 1998; 3: 357-379
        • Medina-Walpole A.
        • Pacala J.T.
        • Potter J.F.
        Geriatric syllabus.
        9th edition. 2016: p106
        • Sandson N.B.
        Appendix A. P450 tables.
        in: Drug interaction casebook. The cytochrome P450 system and beyond. American Psychiatric Publishing, Washing (DC)2003: 251-269
        • Liston H.L.
        • Markowitz J.S.
        • DeVane C.L.
        Drug glucuronidation in clinical psychopharmacology.
        J Clin Psychopharmacol. 2001; 21: 500-515
        • Goldberg R.M.
        • Mabee J.
        • Chan L.
        • et al.
        Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population.
        Am J Merg Med. 1996; 14: 447-450
        • Lindblad C.I.
        • Hanlon J.T.
        • Gross C.R.
        • et al.
        Clinically important drug-disease interactions and their prevalence in older adults.
        Clin Ther. 2006; 28: 1133-1143
        • Rochon P.A.
        • Gurwitz J.H.
        The prescribing cascade revisited.
        Lancet Lon Egl. 2017; 389: 1778-1780
        • Remillard A.J.
        A pharmacoepidemiological evaluation of anticholinergic prescribing patterns in the elderly.
        Pharmacoepidemiol Drug Saf. 1998; 5: 155-164
        • Blazer D.G.
        • Federspiel C.F.
        • Ray W.A.
        • et al.
        The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations.
        J Gerontol. 1983; 38: 31-35
        • Nishtala P.S.
        • Salahudeen M.S.
        • Sarah H.
        Anticholinergics: theoretical and clinical overview.
        Expert Opin Drug Saf. 2016; 15: 753-768
        • Hayes B.D.
        • Klein-Schwartz W.
        • Barrueto F.
        Polypharmacy and the geriatric patient.
        Clin Geriatr Med. 2007; 23-2: 371-390
        • Safari D.
        • DeMarco E.C.
        • Scanlon L.
        • et al.
        Over-the-Counter Remedies in older adults.
        Clin Geriatr Med. 2022; 38: 99-118
      1. American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
        J Am Geriatr Soc. 2019; 67: 674-694
        • O’Mahony D.
        • O’Sullivan D.
        • Byrne S.
        • et al.
        STOPP/START criteria for potentially inappropriate prescribing in older adult: version 2.
        Age Ageing. 2015; 44: 213-218